Yüklüyor......
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202
PURPOSE: Adherence to aromatase inhibitor (AI) therapy for early-stage breast cancer is limited by AI-associated musculoskeletal symptoms (AIMSS). Duloxetine is US Food and Drug Administration approved for treatment of multiple chronic pain disorders. We hypothesized that treatment of AIMSS with dul...
Kaydedildi:
| Yayımlandı: | J Clin Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Clinical Oncology
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5805479/ https://ncbi.nlm.nih.gov/pubmed/29136387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.6651 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|